Comparative study of the effect of atorvastatin and fenofibrate on high‑density lipoprotein cholesterol levels in patients with type 2 diabetes

Comparative study of the effect of atorvastatin and fenofibrate on high‑density lipoprotein cholesterol levels in patients with type 2 diabetes


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: مصطفی نجفی پور , فرزاد نجفی پور

کلمات کلیدی: Atorvastatin, fenofibrate, high‑density lipoprotein cholesterol, type 2 diabetes

نشریه: 50665 , 4 , 9 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فرزاد نجفی پور
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات غدد درون ریز
کد مقاله 65381
عنوان فارسی مقاله Comparative study of the effect of atorvastatin and fenofibrate on high‑density lipoprotein cholesterol levels in patients with type 2 diabetes
عنوان لاتین مقاله Comparative study of the effect of atorvastatin and fenofibrate on high‑density lipoprotein cholesterol levels in patients with type 2 diabetes
ناشر 4
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Diabetes is the most common metabolic disease. Type 2 diabetes is a variable combination of insulin resistance and disorder in insulin secretion, leading to disorder of lipids and plasma lipoproteins. The most common pattern of dyslipidemia in diabetic is high triglyceride (TG) and low high‑density lipoprotein cholesterol (HDL‑C). This study was conducted to find a more effective drug to increase HDL‑C. In this study, 80 patients (26 males and 54 females) with type 2 diabetes received fenofibrate in cross‑sectional way for 2 months, and they did not take antilipid drugs for 2 month. Then, they underwent atorvastatin for 2 months and HDL‑C was measured before and after taking drugs. Patients did not change their diet during this study. Effect of atorvastatin and fenofibrate on HDL‑C levels in patients with type 2 diabetes was evaluated. The mean HDL‑C and total cholesterol (TC) before and after taking drugs were 36.5 mg/dL and 174.56 mg/dL, respectively. After atorvastatin, the mean HDL‑C and TC were 43.30 and 150.144 mg/dL, respectively, and after fenofibrate, 43.40 were mg/dL and 146.36 mg/dL, respectively. Atorvastatin caused increase in HDL‑C by 18.44% and reduction in TC by 13.82% and fenofibrate increase in HDL‑C by18.62% and reduction in TC by 16.05%. No difference was seen between atorvastatin and fenofibrate in terms of effect on the HDL‑C excess (P = 0.449). In addition, no difference was seen between atorvastatin and fenofibrate in terms of effect on TC reduction (P = 0.992). In conclusion various factors are involved in increasing the HDL, such as race, sex, nutrition, physical activity and, of course, medications. The effect of medications is also different on races and genetics. The value of increase in HDL-C after Fenofibrate and Atorvastatin was associated with gender so that it caused more increase of HDL-C in females.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
مصطفی نجفی پوراول
فرزاد نجفی پورچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
atorvastatin and fenofibrate.pdf1397/09/274618772دانلود